Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Novo, Pfizer and obesity

Digest more
 · 1h · on MSN
Novo Nordisk launches bidding war with Pfizer for US obesity biotech Metsera
Pedersen, Louise Rasmussen and Maggie Fick COPENHAGEN (Reuters) -Denmark's Novo Nordisk launched a rival bid for U.S. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer as the drugmakers jostled for advantage in the highly lucrative weight-loss drug market.

Continue reading

C&EN · 31m
Novo Nordisk makes a play for obesity biotech, challenging Pfizer deal
BioSpace · 9h
Novo Nordisk Seeks to Steal Metsera From Pfizer With $8.5B Offer
1h

Metsera the US obesity biotech at centre of Novo, Pfizer bidding war

Metsera has become the obesity drug market's hottest ticket. The New York-based biotech is at the centre of a bidding war ...
6don MSN

Novo Nordisk's new chairman has 'carte blanche' after board clear-out

A boardroom shake-up at Novo Nordisk has handed unprecedented power to its top shareholder, the Novo Nordisk Foundation, ...
1don MSN

Novo Nordisk Shares Fell 5.6% After President Trump Commented on Future Price Cuts for Weight Loss Drugs. Should Investors Be Worried?

Novo Nordisk Shares Fell 5.6% After President Trump Commented on Future Price Cuts for Weight Loss Drugs. Should Investors Be ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics

Pfizer
Metsera
Feedback
  • Privacy
  • Terms